Day: May 10, 2022

Posted on

Reuters Partners with The Globe and Mail’s Sophi.io Automation Platform

TORONTO, May 10, 2022 (GLOBE NEWSWIRE) — Sophi.io, an AI-powered automation, optimization and prediction platform developed by The Globe and Mail, is now working with Reuters – the news and media division of Thomson Reuters – as it continues to invest in the latest AI solutions for its newsroom. Sophi is helping to automate content curation on select sections on Reuters.com, which was relaunched in April 2021.

Sophi Site Automation is an AI system that autonomously curates digital content to find and promote an organization’s most engaging content. Sophi looks at all content as it’s published, and all traffic, to find the hidden gems that an organization’s customers value the most.

In order to automate content curation, Sophi’s algorithm has been learning from Reuters editors. The newsroom has been able to work with some of the latest AI solutions, which has resulted in giving time back to editors to focus on finding the next story and creating the journalism that makes Reuters such a trusted brand.

Josh London, Head of Reuters Professional and Chief Marketing Officer of Reuters, said: “Sophi’s cutting-edge AI platform is one of the next steps in the evolution of our digital properties. Sophi will help us further our mission of bringing AI-based technology and tools to more corners of the workforce, whilst helping to bring our readers the stories they both want and need to know.”

Michael Young, Chief Technology Officer for Reuters, said: “Our partnership with Sophi.io is another example of how a newsroom like ours can successfully deploy some of the latest AI solutions for effective content discovery. Our team worked closely with the Sophi team to ensure our Sophi Score reflected our business goals and we are pleased with the resulting site automation.”

Mike O’Neill, Co-Founder and CEO of Sophi.io, added “We are delighted to have Reuters as a customer. They put their trust in Sophi and we are excited to automate curation across all of their article pages to start and expand the relationship to include more solutions down the road.”

“It’s wonderful to work with Reuters in this capacity,” said Phillip Crawley, Publisher and CEO of The Globe and Mail. “They have a strong mission and Sophi.io is helping them continue to demonstrate how editorial integrity can be supported by AI.”

About Reuters
Reuters is the world’s leading provider of trusted news, insight and analysis, reaching billions of people worldwide every day. Founded in 1851, it brings together world-class journalism, industry expertise and cutting-edge technology with unparalleled speed, reliability and accuracy to enable people to make better decisions. Reuters is committed to the Trust Principles of independence, integrity and freedom from bias, and is the essential source of business, financial and world news delivered to financial professionals exclusively via Refinitiv services, and to the world’s media organizations, industry events and directly to consumers.

About Sophi.io
Sophi.io (https://www.sophi.io) was developed by The Globe and Mail to help content publishers make important strategic and tactical decisions. It is a suite of AI and ML-powered automation, optimization and prediction solutions that include Sophi Site Automation, Sophi for Paywalls and Sophi for First Party Data. Sophi also powers one-click automated laydown of template-free print publishing. Sophi is designed to improve the metrics that matter most to your business, such as subscriber retention and acquisition, engagement, recency, frequency and volume.

Contact us
Kayley Rogers
Communications Manager
Reuters
Kayley.rogers@thomsonreuters.com

Jamie Rubenovitch
Head of Marketing, Sophi.io
The Globe and Mail        
jrubenovitch@globeandmail.com
416-585-3355
Posted on

Taconic Biosciences Appoints Nomura Siam as Distributor in India for All Taconic Animal Models

Improves Access to Critical Rodent Models for Researchers in India

RENSSELAER, N.Y., May 10, 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has appointed Nomura Siam International Co., Ltd (NSI), an established distributor of laboratory animals and related products, as its preferred distributor in India.

India makes a significant contribution to global pharmaceutical and vaccine production, and its pharmaceutical and biotechnology research and development is expected to grow over the next decade. To support this growth, scientists in India need advanced mouse and rat models for pharmacology studies and toxicology and drug safety assessment. Research across all therapeutic areas requires genetically engineered models (GEMs). Additionally, mice with humanized immune systems are critical for immuno-oncology and other applications.

Taconic’s portfolio comprises nearly 4,700 mouse and rat models, including widely used standard strains, immunodeficient models, and exclusive GEMs. Taconic is also a global leader in humanized immune system mouse generation. Taconic’s industry-leading quality systems, genetic integrity, and globally harmonized animal health standards promote research reproducibility while its flexible approach to licensing reduces barriers to accessing valuable GEMs.

Based in Thailand, NSI is known for its focus on quality and customer service. The company’s new agreement with Taconic significantly increases preclinical researchers’ access to GEMs in India and allows NSI to offer this market a full spectrum of solutions.

“To date, rodent model selection and availability has been somewhat limited in India. We believe this partnership will provide India’s growing pharmaceutical industry access to the most sophisticated and high-quality animal models available globally,” said Dr. Michael Seiler, vice president of commercial products at Taconic. “We truly believe this partnership will support Taconic’s desire to accelerate new life-saving therapeutics for the global community.”

“Taconic’s portfolio of sophisticated mouse models fills a major gap in the Indian market,” said Taiichiro Kamiya, president of NSI. “By our frequent information sharing, and the improvement of logistic process, we will provide faster and easier access to GEMs for Indian users.”

To learn more about Taconic’s full line of animal model solutions, please call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email info@taconic.com.

About Taconic Biosciences, Inc.

Taconic Biosciences is a fully licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates service laboratories and breeding facilities in the US and Europe, maintains distributor relationships in Asia, and has global shipping capabilities to provide animal models almost anywhere in the world.

About Nomura Siam International Co. Ltd. (NSI)

Nomura Siam International Co. Ltd., based in Bangkok, Thailand, was jointly established in 2012 by CLEA Japan, Inc. and Nomura Jimusho, Inc. as a comprehensive provider for the laboratory animal field. As a one-stop service supplier, NSI not only sells laboratory animals but also handles a wide range of related products, including equipment for breeding, conducting experiments, and environmental enrichment, as well as consulting services for preclinical research and laboratory animal facility design.

Media Contact:

Aidan Bouchelle
Associate Director, Marketing Operations
518-949-7598
Aidan.Bouchelle@taconic.com

Posted on

Taconic Biosciences Nomeia Nomura Siam como Distribuidora para Todos os Modelos Animais da Taconic na Índia

Acesso aprimorado aos modelos críticos de roedores para pesquisadores na Índia

RENSSELAER, NY, May 10, 2022 (GLOBE NEWSWIRE) — A Taconic Biosciences, líder global no fornecimento de soluções de modelo de animais para a descoberta de medicamentos, anunciou a nomeação da Nomura Siam International Co., Ltd. (NSI), distribuidora de animais de laboratório e produtos afins, como sua distribuidora preferida na Índia.

A Índia contribui significativamente para a produção global de produtos farmacêuticos e vacinas, e a sua investigação e desenvolvimento farmacêuticos e biotecnológicos devem crescer ao longo da próxima década. Para apoiar esse crescimento, os cientistas na Índia precisam de modelos avançados de camundongos e ratos para estudos de farmacologia e toxicologia e avaliação da segurança dos medicamentos. A pesquisa em todas as áreas terapêuticas requer modelos geneticamente modificados (GEMs). Além disso, camundongos com sistemas imunológicos humanizados são essenciais para a imuno-oncologia e outras aplicações.

O portfólio da Taconic abrange quase 4.700 modelos de camundongos e ratos, incluindo cepas padrão amplamente usadas, modelos imunodeficientes e GEMs exclusivas. A Taconic também é líder global na geração de camundongos com sistema imunológico humanizado. Os sistemas de qualidade líderes, a integridade genética e os padrões de saúde animal harmonizados em todo o mundo da indústria da Taconic, promovem a reprodutibilidade da pesquisa, enquanto sua abordagem flexível ao licenciamento reduz as barreiras ao acesso aos GEMs valiosos.

Com sede na Tailândia, a NSI é conhecida pelo seu foco na qualidade e atendimento ao cliente. O novo acordo da empresa com a Taconic aumenta significativamente o acesso de pesquisadores pré-clínicos aos GEMs na Índia e permite que a NSI ofereça a este mercado um espectro completo de soluções.

“Até agora a seleção e a disponibilidade de modelos de roedores têm sido um pouco limitadas na Índia. Acreditamos que esta parceria fornecerá à indústria farmacêutica da Índia crescente acesso aos modelos animais mais sofisticados e de alta qualidade disponíveis em todo o mundo”, disse o Dr. Michael Seiler, vice-presidente de produtos comerciais da Taconic. “Nós realmente acreditamos que esta parceria apoiará o desejo da Taconic de acelerar novas terapêuticas que salvam vidas para a comunidade global.”

“O portfólio da Taconic de modelos sofisticados de camundongos preenche uma grande lacuna no mercado na Índia”, disse Taiichiro Kamiya, presidente da NSI. “Com o nosso compartilhamento frequente de informações e a melhoria do processo logístico, forneceremos acesso mais rápido e fácil às GEMs para os usuários indianos.”

Para mais informações sobre a linha soluções de modelo de animais da Taconic, ligue para 1-888-TACONIC (888- 822- 6642) nos EUA, +45 70 23 04 05 na Europa, ou envie email para info@taconic.com.

Sobre a Taconic Biosciences, Inc.

A Taconic Biosciences é uma líder global totalmente licenciada em serviços e modelos geneticamente modificados. Fundada em 1952, a Taconic oferece as melhores soluções/modelos de pesquisas em murinos, para que os clientes possam adquirir, customizar, criar, pré-condicionar, testar e distribuir valiosos modelos de pesquisa em todo o mundo. Especializada em modelos de camundongos e de ratos geneticamente projetados, microbioma, modelos de camundongos imuno-oncologia, e serviços de design e criação de modelos integrados, a Taconic opera laboratórios de serviços e instalações de criação nos EUA e na Europa, mantém relações com distribuidores na Ásia , e tem capacidades de entrega em nível global para oferecer modelos em quase qualquer lugar no mundo.

Sobre a Nomura Siam International Co. Ltd. (NSI)

A Nomura Siam International Co. Ltd., com sede em Bangkok, Tailândia, foi criada em 2012 pela CLEA Japan, Inc. juntamente com a Nomura Jimusho, Inc. como fornecedora abrangente para o campo de animais de laboratório. Como fornecedora completa de serviços únicos, a NSI, além de vender animais de laboratório, também lida com uma ampla gama de produtos afins, incluindo equipamentos para criação de animais e experimentos, enriquecimento ambiental, bem como fornece serviços de consultoria para pesquisa pré-clínica e instalações de projetos com animais de laboratório.

Contato com a Mídia:

Aidan Bouchelle
Diretor Associado, Operações de Marketing
518-949-7598
Aidan.Bouchelle@taconic.com

Posted on

Taconic Biosciences nomme Nomura Siam comme distributeur en Inde pour tous les modèles animaux Taconic

Amélioration de l’accès aux modèles de rongeurs critiques pour les chercheurs en Inde

RENSSELAER, New York, 10 mai 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, l’un des leaders mondiaux des solutions de modèles animaux pour la mise au point de médicaments, a nommé Nomura Siam International Co., Ltd (NSI), distributeur établi d’animaux de laboratoire et de produits connexes, comme son distributeur privilégié en Inde.

L’Inde apporte une contribution significative à la production mondiale de produits pharmaceutiques et de vaccins, et sa recherche et son développement pharmaceutiques et biotechnologiques devraient connaître une réelle croissance au cours de la prochaine décennie. Afin de soutenir celle-ci, les scientifiques indiens ont besoin de modèles avancés de souris et de rats pour les études pharmacologiques et l’évaluation de la toxicologie et de l’innocuité des médicaments. La recherche dans tous les domaines thérapeutiques nécessite des modèles génétiquement modifiés (MGM). En outre, les souris dotées de systèmes immunitaires humanisés sont essentielles pour l’immuno-oncologie et d’autres applications.

Le portefeuille de Taconic comprend près de 4 700 modèles de souris et de rats, y compris des souches standard largement utilisées, des modèles immunodéficients et des MGM exclusifs. Taconic est également un leader mondial de la génération de souris à système immunitaire humanisé. Les systèmes de qualité, l’intégrité génétique et les normes de santé animale harmonisées à l’échelle mondiale leaders du secteur de Taconic favorisent la reproductibilité des études, tandis que son approche flexible des licences réduit les obstacles à l’accès à de précieux MGM.

Basée en Thaïlande, NSI est connue pour son accent mis sur la qualité et le service à la clientèle. Le nouvel accord de la société avec Taconic augmente considérablement l’accès aux MGM pour les chercheurs précliniques en Inde et permet à NSI d’offrir à ce marché une gamme complète de solutions.

« À ce jour, la sélection et la disponibilité des modèles de rongeurs ont été quelque peu limitées en Inde. Nous sommes convaincus que ce partenariat fournira à l’industrie pharmaceutique indienne en plein croissance un accès aux modèles animaux les plus sophistiqués et de haute qualité disponibles à l’échelle mondiale », a déclaré le Dr Michael Seiler, vice-président des produits commerciaux chez Taconic. « Nous sommes vraiment convaincus que ce partenariat aidera Taconic dans son désir d’accélérer de nouveaux traitements vitaux pour la communauté mondiale. »

« Le portefeuille de modèles de souris sophistiqués de Taconic comble une lacune majeure sur le marché indien », a commenté Taiichiro Kamiya, président de NSI. « Grâce à notre partage fréquent d’informations et à l’amélioration du processus logistique, nous fournirons aux utilisateurs indiens un accès plus rapide et plus facile aux MGM. »

Pour en savoir plus sur la gamme complète de solutions de modèles animaux de Taconic, veuillez composer le 1-888-TACONIC (888-822-6642) aux États-Unis, le +45 70 23 04 05 en Europe, ou envoyer un e-mail à l’adresse info@taconic.com.

À propos de Taconic Biosciences, Inc.

Taconic Biosciences est un leader mondial pleinement agréé dans les modèles et les services de rongeurs génétiquement modifiés. Fondée en 1952, Taconic offre les meilleures solutions animales afin que les clients puissent acquérir, générer d’une manière personnalisée, élever, pré-conditionner, tester et distribuer des modèles de recherche précieux dans le monde entier. Spécialiste des modèles de souris et de rats génétiquement modifiés, du microbiome, des modèles de souris pour l’immuno-oncologie et des services de conception de modèles intégrés et d’élevage, Taconic exploite des laboratoires de services et des établissements d’élevage aux États-Unis et en Europe, entretient des relations de distribution en Asie et dispose de capacités d’expédition mondiales pour fournir des modèles animaux presque partout dans le monde.

À propos de Nomura Siam International Co. Ltd. (NSI)

Nomura Siam International Co. Ltd., entreprise sis à Bangkok (Thaïlande), a été créée conjointement en 2012 par CLEA Japan, Inc. et Nomura Jimusho, Inc. en tant que fournisseur exhaustif dans le domaine des animaux de laboratoire. En tant que prestataire de services unifiés, NSI commercialise non seulement des animaux de laboratoire, mais gère également une vaste gamme de produits connexes, y compris des équipements destinés à l’élevage, à la réalisation d’expériences et à l’enrichissement environnemental, ainsi que des services de conseil en matière de recherche préclinique et la conception de sites pour animaux de laboratoire.

Contact auprès des médias :

Aidan Bouchelle
Directeur associé en charge des opérations marketing
518-949-7598
Aidan.Bouchelle@taconic.com

Posted on

Procter & Gamble announces new commitments and shares progress on actions to strengthen Equality & Inclusion across Asia Pacific, the Middle-East, and Africa

The commitments were announced at the P&G #WeSeeEqual regional summit that saw participation from global equality and inclusion advocates like Simone Biles, Dr.  Nawal Al Hosany, Anita Bhatia, Valerie Jarrett, among others

SINGAPORE, May 10, 2022 /PRNewswire/ — Procter & Gamble (NYSE:PG) today announced new commitments aimed toward advancing Equality & Inclusion across Asia Pacific, the Middle East, and Africa, at its fourth annual #WeSeeEqual summit for the region. The event saw participation from distinguished advocates and personalities from the private and public sectors who came together to discuss the challenges that society faces on equality and inclusion, and how different stakeholders can accelerate progress in the new normal.

Built on the theme, ‘#Unlearn and #Unleash‘, the summit saw P&G commit to several actions needed to advance progress towards creating an equal and inclusive world. P&G President for Asia Pacific, Middle East, and Africa, Magesvaran Suranjan, announced the following commitments:

  • P&G will spend a cumulative total of $300 million US dollars by deliberately working with women-owned and women-led businesses across the Asia Pacific, Middle East, and Africa region, from the year 2021 to 2025.
    • Last year, P&G committed to spending a cumulative total of $200 million US dollars by deliberately working with women-owned and women-led businesses across the region, from the year 2021 to 2025. With already more than $100 million US dollars invested through this initiative in the first year across the AMA region, the company is now elevating this commitment to $300 million US dollars by 2025.
  • P&G will achieve equal representation of female directors behind the camera for the company’s brand advertisements in Asia Pacific, Middle East, and Africa, by 2024.
    • In the AMA region, P&G has made strong progress, increasing representation of female directors from 16% in 2019 to 35% today. The company will achieve the 50-50 goal by 2024 through a comprehensive set of actions to build, fuel, and connect a pipeline of diverse female talent in advertising, media, and content.
  • P&G will improve the accessibility of its brand advertising, including social media content and websites, by making it accessible to people with sight and hearing impairments by 2024.
    • The company will do this for all new brand advertising across Asia Pacific, the Middle East, and Africa. This initiative will make P&G brands more inclusive and accessible to all members of our community.
  • P&G will introduce the ‘P&G ReLaunch program’ – to welcome back talented professionals who took a break from the workforce and are looking to restart their careers in STEM roles, with targeted support and development.
    • This program is part of the company’s commitment to strengthen diversity in STEM (Science, Technology, Engineering and Mathematics) and will focus on people looking to relaunch their careers in IT, Research & Development, and Product Supply. The program will be first launched in India, Egypt, Singapore, Japan, and the Philippines.

Magesvaran Suranjan said: “At P&G, we remain fully committed to creating a world where equal access and opportunity to learn, grow, succeed, and thrive are available to everyone. We believe in the power of our differences and the impact we can make when we come together, united by our shared values and purpose. We are making great progress, yet we know there is more work to be done. So we are announcing bold new commitments and expanding existing actions which will enable us to do more. We will continue to use the voice of our company and our brands in forums such as #WeSeeEqual to drive discussion and actions on the issues that matter.”

The company also shared strong progress on commitments across the Asia Pacific, Middle East, and Africa region made last year as part of the annual #WeSeeEqual summit. In 2021, P&G announced its ‘Share the Care’ parental leave policy, which has introduced greater leave benefits and flexibility for all new parents within the company. P&G has also achieved its commitment to achieving a 50-50 gender balance across its management workforce by 2022 in the AMA region, completing this ahead of schedule. On its commitment to educate more than 30 million girls on puberty and hygiene by 2024, through its brands Always and Whisper‘s “Keeping Girls in School” program, the company has already reached more than 15 million girls, achieving the halfway mark in one year.

Held in partnership with UN Women, the fourth annual regional #WeSeeEqual Summit engaged business leaders, government officials, and personalities in candid conversations around strategic actions that can be taken to advance equality and inclusion.

In addition to global and regional P&G leaders, the Summit also saw the participation of influential personalities and global leaders, including:

  • Simone Biles, the world’s most decorated gymnast
  • Valerie Jarrett, Chief Executive Officer, The Barack Obama Foundation
  • Her Excellency Dr. Nawal Al Hosany, UAE’s permanent representative to the International Renewable Energy Agency (IRENA)
  • Anita Bhatia, Assistant Secretary-General and Deputy Executive Director, UN Women
  • Alma Har’el, award-winning director, founder of Free the Bid and FREE THE WORK
  • Dr. Hsien Hsien Lei, Chief Executive Officer, The American Chamber of Commerce, Singapore
  • Scott Beaumont, President, Google – Asia Pacific
  • Lillian Barnard, Chief Executive Officer, Microsoft – South Africa

To inspire corporates and society alike, the summit also hosted P&G’s Chief Operating Officer, Shailesh Jejurikar, and the company’s Chief Brand Officer, Marc Pritchard to share their experiences and insights on the importance of leadership to drive equality and redefine inclusion behind the camera.

The #WeSeeEqual program demonstrates P&G’s continued commitment to creating a more equal and inclusive world and is also a winner of the U.S. Secretary of State’s Award for Corporate Excellence for Women’s Empowerment in 2019. As one of the world’s largest advertisers, P&G and its brands will also continue to leverage their influential voice in media and advertising to drive further awareness, tackle gender bias, spark conversations, and motivate change.

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.

Photo – https://mma.prnewswire.com/media/1814474/WSE_2022_KV_FINAL_1.jpg
Logo – https://mma.prnewswire.com/media/1571597/Procter_and_Gamble_logo.jpg

Posted on

Huawei OceanStor Distributed Storage Is Named as a 2022 Gartner Peer Insights Customers’ Choice for Distributed File Systems and Object Storage

SHENZHEN, China, May 10, 2022 /PRNewswire/ — Gartner Peer Insights recognized Huawei OceanStor distributed storage as a Customers’ Choice in the 2022 Gartner Peer Insights ‘Voice of the Customer’: Distributed File Systems and Object Storage report. Scoring 4.9 out of 5 points on the annual Gartner Peer Insights platform, Huawei OceanStor distributed storage ranked first among all global vendors.

Gartner Peer Insights is an online ratings and reviews platform for IT software and services. The reviews are written and read by IT professionals and technology decision-makers worldwide. It includes more than 380,000 verified reviews from end-users who have experience purchasing, implementing, or using products or services in over 360 markets. Each year, vendors with high customer ratings are named a Gartner Peer Insights Customers’ Choice, helping IT leaders make more informed purchasing decisions.

As of January 31, 2022, Huawei OceanStor distributed storage products and solutions had received many positive reviews from customers around the world and in various industries, such as finance, carrier, manufacturing, energy, media, healthcare, and education. These reviews cover everything from system architecture, product functionality, and deployment to O&M, service, and support. All of these highlight how global customers think of Huawei OceanStor distributed storage in terms of industry position, deployment scale, and commercial use maturity.

“We are very grateful for our customers sharing their opinions on Gartner Peer Insights. Our only goal is to provide solutions and products that make our customers happy,” Mr. Wang Yidong, President of Huawei Distributed Storage Domain, said, “We will continue to focus on our customers’ needs and keep providing efficient and reliable distributed storage products and solutions to safeguard innovative services in each and every industry.”

Confirming this customer focus, one industry architect commented, “We are deeply impressed by the customer-centric working attitude of Huawei engineers. The product itself is very responsive, easy to use for unstructured data, and highly scalable.”

“We need a new type of storage to replace the traditional centralized storage. After POC test, we found that the reliability and scalability of Huawei distributed storage can be realized. The storage capacity can be expanded quickly and the management interface functions are complete,” wrote one IT technical director in the finance industry.

A review from a CTO in the manufacturing sector stated, “Huawei is experienced on distributed storage product. The storage is stable with different networks. And I do like the unified platform idea.”

Specially designed to accommodate mass data, Huawei OceanStor distributed storage provides diversified storage services for high-performance computing (HPC), big data analytics, video, content repository/backup and archiving, virtualization, and cloud resource pools. It helps enterprises fully unleash the value of mass data.

Photo – https://mma.prnewswire.com/media/1814234/image_1.jpg

Proudly powered by WordPress